Table 2. The characteristics of the participants between benign group and malignant group.
| Variables | Malignant group | Benign group | P value |
|---|---|---|---|
| Numbers | 200 | 187 | |
| Age (years) | 50.1 (9.5) | 49.7 (6.2) | 0.652 |
| BMI (kg/m2) | 23.2 (4.2) | 23.7 (4.3) | 0.273 |
| Menopausal status | |||
| (Postmenopausal, %) | 123 (61.5) | 125 (66.8) | 0.273** |
| FPG (mmol/L) | 5.20 (4.90-5.58) | 5.00 (4.70-5.40) | < 0.001* |
| WBC (×109/L) | 6.1 (1.8) | 6.4 (1.6) | 0.081 |
| Haemoglobin (g/dl) | 134.8 (11.9) | 132.3 (13.9) | 0.057 |
| Platelet (×109/L) | 232.3 (49.4) | 255.3 (53.2) | < 0.001 |
| MPV (fL) | 9.1 (1.1) | 9.8 (1.2) | < 0.001 |
| PDW (%) | 16.7 (1.0) | 14.5 (2.3) | < 0.001 |
| Fibrinogen (g/l) | 2.83 (0.66) | 2.42 (0.43) | < 0.001 |
| CEA (ng/ml) | 1.30 (0.84–1.98) | 0.93 (0.48–1.31) | < 0.001* |
| CA15-3 (U/ml) | 9.35 (6.91–12.78) | 4.01 (2.61–7.39) | < 0.001* |
Values are shown as mean (standard deviation) or median (IQR) or percentage. BMI, body mass index; FPG, fasting plasma glucose; WBC, white blood cell; MPV, mean platelet volume; PDW, platelet distribution width; CEA, carcinoembryonic antigen; CA15-3, cancer antigen 15-3. P-value was obtained using independent samples t-test. *P-value was obtained using Mann-Whitney U test. **P-value was obtained using chi-square test.